| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |